Mary T. Szela, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 2,569 shares at $52.92 ($136K) on 2008-06-30, disclosed to the SEC on 2008-06-30.
Scheduled sale ($136k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.90 | 1,569 | $83K | 61.1% |
| 2 | $52.91 | 600 | $32K | 23.4% |
| 3 | $52.92 | 400 | $21K | 15.6% |
| Total | $52.91 avg | 2,569 | $136K | 100% |
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |